Edwards Lifesciences Corp (EW)

73.91 +1.32 (+1.82%) USD  |  NYSE  |  Jan 03, 16:00
73.87 -0.04 (-0.05%) After-Hours: 20:00
More

Edwards Lifesciences Research and Development Expense (Quarterly): 253.40M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for EW.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Boston Scientific Corp 407.00M
NeuroOne Medical Technologies Corp 1.114M
SINTX Technologies Inc 0.796M
Nutriband Inc 0.8808M
enVVeno Medical Corp 2.859M